Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives $27.50 Average Target Price from Analysts
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the six research firms that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1-year price objective […]
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the six research firms that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1-year price objective […]
